Faeth Therapeutics, Inc.
FTHNasdaqCIK 1829802HealthcareFiscal year ends Dec 31
Reports and events: 126 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2707:33 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-432688 |
| 2026-09-1716:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-394360 |
| 2026-08-0407:40 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-331562 |
| 2026-08-0407:40 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-331563 |
| 2026-07-2317:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-314591 |
| 2026-06-1817:13 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-276093 |
| 2026-06-1508:16 ET | 8-K | 1.02 Termination of a material agreement; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-270330 |
| 2026-06-1016:21 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-265879 |
| 2026-06-0209:01 ET | 10-K/A | Annual report, amendedPeriod 2025-12-31 | 0001193125-26-252637 |
| 2026-05-2216:01 ET | 8-K | 8.01 Other events | 0001193125-26-236820 |
| 2026-05-2117:12 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-234882 |
| 2026-05-1507:40 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-225333 |
| 2026-05-1507:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-225323 |
| 2026-04-2716:19 ET | DEF 14A | Proxy statementPeriod 2026-06-10 | 0001193125-26-182143 |
| 2026-04-1616:02 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-158951 |
| 2026-04-1516:15 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001193125-26-157038 |
| 2026-03-3017:35 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-132014 |
| 2026-03-3007:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-130419 |
| 2026-02-1808:45 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-056135 |
| 2026-02-1317:29 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-051815 |
| 2025-12-2317:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-25-331113 |
| 2025-11-1407:45 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-281590 |
| 2025-11-1407:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-281581 |
| 2025-10-3009:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-257621 |
| 2025-10-1708:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-242007 |
| 2025-08-0516:30 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-103101 |
| 2025-08-0507:31 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-173043 |
| 2025-07-0916:30 ET | 8-K | 3.01 Delisting notice | 0001193125-25-157113 |
| 2025-06-1307:33 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-25-140329 |
| 2025-05-2308:00 ET | 8-K | 5.07 Shareholder vote results | 0001193125-25-125484 |
| 2025-05-0616:30 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-064525 |
| 2025-05-0607:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-113299 |
| 2025-04-1108:00 ET | DEF 14A | Proxy statementPeriod 2025-05-21 | 0000950170-25-053033 |
| 2025-03-2807:45 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-046338 |
| 2025-03-2807:36 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-066261 |
| 2025-03-2717:20 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-065634 |
| 2025-01-0717:18 ET | 8-K | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001193125-25-002920 |
| 2024-11-1408:03 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-126748 |
| 2024-11-1407:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-258006 |
| 2024-10-3016:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-24-247599 |
| 2024-09-2016:31 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-24-222937 |
| 2024-08-0616:30 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-091895 |
| 2024-08-0607:36 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-194428 |
| 2024-07-1216:31 ET | 8-K | 3.01 Delisting notice | 0001193125-24-178607 |
| 2024-06-2717:01 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-24-170690 |
| 2024-06-1316:45 ET | 8-K | 5.07 Shareholder vote results | 0001193125-24-160769 |
| 2024-06-0307:31 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-152363 |
| 2024-05-2317:10 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-146093 |
| 2024-05-0916:31 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-057106 |
| 2024-05-0907:37 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-134767 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 16:18 ET. Listed shows no prices and gives no investment advice.